Skip to content

Midline Catheter and Its Impact on Central Lines Removal in ICU

Midline Catheter and Its Impact on Central Lines Removal in ICU

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03675711
Acronym
MIDREA
Enrollment
83
Registered
2018-09-18
Start date
2018-11-02
Completion date
2023-01-13
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Access Device

Brief summary

The study will evaluate 2 strategies to remove central venous catheter (CVC): in one part, the insertion of a midline catheter and in the other part, the conventional insertion of peripheral venous catheter (PVC)

Detailed description

Patients will be randomised when the last indication for CVC has disappeared, which means parenteral nutrition or vasopressors administration. They will be randomised either in the midline group or in the PVC group. * In the midline group, a midline catheter will try to be inserted before the 48th hour after last indication for CVC disappeared. * In the PVC group: a PVC will try to be inserted before the 48th hour after last indication for CVC disappeared. If successful, CVC will then be removed. If not, a PVC will try to be inserted daily till success or worthlessness of a venous line or death. The presence of a CVC will be assessed at the 96th hour after disappearance of last CVC indication.

Interventions

DEVICEMidline

Patient will receive a Midline catheter within 48h after disappearance of indication for CVC

DEVICEPVC

Patient will receive a standard PVC within 48h after disappearance of indication for CVC

Sponsors

Centre Hospitalier Departemental Vendee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

supportive care

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years of age * admitted to ICU since at least 48h * with a perfusion CVC inserted * requiring or having required invasive mechanical ventilation * lack of formal indication to CVC maintenance (weaning of vasopressors and/or parenteral nutrition) since at least 24 hours * indication to maintain a venous access

Exclusion criteria

* Lack of patient or next of kin consent * Personnel for insertion of midline catheter not available * Admission in ICU before study start * Admission following a transfer from another ICU * Patient with an implantable port or a peripherally inserted central catheter (PICC Line) * Known intolerance to components of study Midline device * Past history of irradiation of insert area of midline catheter * Past history of bilateral axillary lymph node dissection * Pre-existing skin infection on upper limb * Patient with a treatment-limitation decision * Patient admitted after cardiac arrest with non-shockable rhythm * Moribund * Pregnancy, breastfeeding woman * Patient under legal guardianship * Patient hospitalized without consent and/or deprived of liberty by court's decision

Design outcomes

Primary

MeasureTime frameDescription
% of patient with a successful Removal of CVC at the 96th hour after disappearance of last indication for CVCH96 : 96th hour after disappearance of last indication for CVCA successful removal of CVC is defined as * success of midline/PVC insertion at H96 and consequently CVC removal * and no necessity for insertion of a new CVC within the 96 first hours

Secondary

MeasureTime frameDescription
Time consumptionuntil 28 days after randomisationTotal time of catheterisation, (measured from the entrance in patient room, to the exit)
Number of peripheral catheter-associated bacteremiauntil 28 days after randomisation
ICU length of stayUntil discharge from ICU, an expected average of 12 days
hospital mortalityUntil discharge from hospital, an expected average of 20 daysmortality in medical and surgical unit (no SSR or long stay)
Hospital length of stayUntil discharge from hospital, an expected average of 20 daysHospital stay in medical and surgical unit (no follow-up and rehabilitation care unit or long stay)
Total number of puncture required for the insertion of a peripheral catheteruntil 28 days after randomisation
Total number of peripheral catheter useduntil 28 days after randomisation
Number of new CVC inserteduntil 28 days after randomisation
ICU mortalityUntil discharge from ICU, an expected average of 12 days
Number of blood culture for research of catheter-related bloodstream infection (CRBSI)until 28 days after randomisation
CVC dwell timefrom disappearance of CVC indication to last CVC removal or 28 days after randomisation if still in placeTime of central catheter duration (hours)
Number of CVC colonized for per 1000 CVC /daysuntil 28 days after randomisation
Number of CVC-associated bacteremiauntil 28 days after randomisation

Other

MeasureTime frameDescription
Colonization of skin at insert point of Midline catheteruntil 28 days after randomisationswabbing will be performed at every change of dressing
Thrombosis at Midline removaluntil removal in ICU,an expected average of 10 days after insertionthrombosis will be checked by ultrasound-echography if midline is removed in ICU
Colonization of Midline at removaluntil removal,an expected average of 10 days after insertionswabbing will be performed at catheter removal and its tips will be also analyzed

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026